Streetbeat News

Analyst Ratings

OHI

Mizuho analyst Haendel St. Juste maintains a Neutral rating on Omega Healthcare Invts (NYSE:OHI) and lowers the price target from $32 to $31.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 10:49 am

VTR

Mizuho analyst Vikram Malhorta maintains a Buy rating on Ventas (NYSE:VTR) but lowers the price target from $60 to $53.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 10:48 am

XEL

Mizuho analyst Anthony Crowdell maintains a Buy rating on Xcel Energy (NASDAQ:XEL) but lowers the price target from $72 to $69.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 10:44 am

CCCC

Evercore ISI Group analyst Gavin Clark-Gartner maintains an Outperform rating on C4 Therapeutics (NASDAQ:CCCC) but lowers the price target from $20 to $10.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 10:43 am

COO

Needham analyst David Saxon maintains a Hold rating on Cooper Companies (NYSE:COO).

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 10:42 am

CRM

Wells Fargo analyst Michael Turrin maintains an Overweight rating on Salesforce (NYSE:CRM) and raises the price target from $225 to $250.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 10:42 am

NOW

Bernstein analyst Peter Weed maintains an Outperform rating on ServiceNow (NYSE:NOW) and raises the price target from $586 to $665.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 10:40 am

COLL

Needham analyst Serge Belanger has reiterated a Buy rating on Collegium Pharmaceutical (NASDAQ:COLL) and maintained a $35 price target.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 10:38 am

HRMY

Needham analyst Ami Fadia reiterates a Buy rating on Harmony Biosciences (NASDAQ:HRMY) and maintains a $67 price target.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 10:36 am

JAZZ

Needham analyst Ami Fadia reiterates a Buy rating on Jazz Pharmaceuticals (NASDAQ:JAZZ) and raises the price target from $212 to $226.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 10:35 am